Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shandong Jincheng Haise Pharmaceutical Co., Ltd., a core subsidiary of the Jincheng Pharmaceutical Group, is a comprehensive pharmaceutical enterprise based in Zibo, China. The company specializes in the research, development, and large-scale production of active pharmaceutical ingredients (APIs) and finished oral solid dosage forms. Its primary therapeutic focus includes anti-infectives, particularly cephalosporin antibiotics, and cardiovascular medications such as antihypertensives. Jincheng Haise operates modern manufacturing facilities that adhere to strict global GMP standards, serving both the Chinese domestic market and international clients. As an integrated manufacturer, the company leverages its parent group's chemical expertise to maintain a robust supply chain from intermediates to finished drug products.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jincheng Haise Pharmaceutical.